Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This randomized phase II trial studies how well docosahexaenoic acid works in preventing recurrence in breast cancer survivors. Docosahexaenoic acid supplement may prevent recurrence in breast cancer survivors.
Epistemonikos ID: c24ddeab35d436c9e527eca4cb2d52de23596d32
First added on: May 11, 2024